DAVITA INC. Contract with Customer, Asset, after Allowance for Credit Loss
DAVITA INC. (DVA) had Contract with Customer, Asset, after Allowance for Credit Loss of $310.54 million as of 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Balance Sheet › Assets
us-gaap:ContractWithCustomerAssetNet · last filed 2026-02-11
- 2025-12-31: Contract with Customer, Asset, after Allowance for Credit Loss $310.54M.
- 2024-12-31: Contract with Customer, Asset, after Allowance for Credit Loss $251.07M.
| Period end | Contract with Customer, Asset, after Allowance for Credit Loss |
|---|---|
| 2025-12-31 | $310.54M 10-K · filed 2026-02-11 |
| 2024-12-31 | $251.07M 10-K · filed 2026-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |